nodes	percent_of_prediction	percent_of_DWPC	metapath
Alogliptin—CYP2D6—Lomustine—hematologic cancer	0.0582	0.0738	CbGbCtD
Alogliptin—CYP2D6—Idarubicin—hematologic cancer	0.0519	0.0658	CbGbCtD
Alogliptin—CYP2D6—Hydroxyurea—hematologic cancer	0.0441	0.0559	CbGbCtD
Alogliptin—CYP3A4—Bexarotene—hematologic cancer	0.0398	0.0505	CbGbCtD
Alogliptin—CYP2D6—Bortezomib—hematologic cancer	0.0384	0.0487	CbGbCtD
Alogliptin—CYP3A4—Busulfan—hematologic cancer	0.037	0.0469	CbGbCtD
Alogliptin—CYP3A4—Lomustine—hematologic cancer	0.037	0.0469	CbGbCtD
Alogliptin—CYP3A4—Thiotepa—hematologic cancer	0.033	0.0418	CbGbCtD
Alogliptin—CYP2D6—Imatinib—hematologic cancer	0.0281	0.0357	CbGbCtD
Alogliptin—CYP3A4—Methoxsalen—hematologic cancer	0.0257	0.0325	CbGbCtD
Alogliptin—CYP2D6—Nilotinib—hematologic cancer	0.0256	0.0324	CbGbCtD
Alogliptin—CYP2D6—Vinorelbine—hematologic cancer	0.0253	0.0321	CbGbCtD
Alogliptin—CYP3A4—Bortezomib—hematologic cancer	0.0244	0.0309	CbGbCtD
Alogliptin—CYP3A4—Daunorubicin—hematologic cancer	0.0233	0.0296	CbGbCtD
Alogliptin—CYP3A4—Cytarabine—hematologic cancer	0.0206	0.0261	CbGbCtD
Alogliptin—CYP3A4—Teniposide—hematologic cancer	0.0203	0.0257	CbGbCtD
Alogliptin—CYP3A4—Ifosfamide—hematologic cancer	0.0187	0.0237	CbGbCtD
Alogliptin—CYP3A4—Imatinib—hematologic cancer	0.0179	0.0227	CbGbCtD
Alogliptin—CYP3A4—Ruxolitinib—hematologic cancer	0.0168	0.0213	CbGbCtD
Alogliptin—CYP3A4—Nilotinib—hematologic cancer	0.0163	0.0206	CbGbCtD
Alogliptin—CYP3A4—Vinorelbine—hematologic cancer	0.0161	0.0204	CbGbCtD
Alogliptin—CYP2D6—Vinblastine—hematologic cancer	0.0156	0.0198	CbGbCtD
Alogliptin—CYP3A4—Triamcinolone—hematologic cancer	0.0147	0.0187	CbGbCtD
Alogliptin—CYP3A4—Dasatinib—hematologic cancer	0.0144	0.0182	CbGbCtD
Alogliptin—CYP3A4—Mitoxantrone—hematologic cancer	0.0142	0.018	CbGbCtD
Alogliptin—CYP3A4—Betamethasone—hematologic cancer	0.0126	0.016	CbGbCtD
Alogliptin—CYP3A4—Prednisolone—hematologic cancer	0.0125	0.0158	CbGbCtD
Alogliptin—CYP3A4—Prednisone—hematologic cancer	0.0118	0.0149	CbGbCtD
Alogliptin—CYP2D6—Dexamethasone—hematologic cancer	0.0116	0.0147	CbGbCtD
Alogliptin—CYP3A4—Irinotecan—hematologic cancer	0.0112	0.0142	CbGbCtD
Alogliptin—CYP3A4—Vinblastine—hematologic cancer	0.00993	0.0126	CbGbCtD
Alogliptin—CYP3A4—Vincristine—hematologic cancer	0.00976	0.0124	CbGbCtD
Alogliptin—CYP2D6—Doxorubicin—hematologic cancer	0.0096	0.0122	CbGbCtD
Alogliptin—CYP3A4—Etoposide—hematologic cancer	0.00895	0.0113	CbGbCtD
Alogliptin—CYP3A4—Dexamethasone—hematologic cancer	0.00736	0.00932	CbGbCtD
Alogliptin—CYP3A4—Doxorubicin—hematologic cancer	0.0061	0.00774	CbGbCtD
Alogliptin—Linagliptin—ABCB1—hematologic cancer	0.0022	1	CrCbGaD
Alogliptin—Hypersensitivity—Methoxsalen—hematologic cancer	0.000608	0.003	CcSEcCtD
Alogliptin—Pancreatitis—Cisplatin—hematologic cancer	0.000604	0.00298	CcSEcCtD
Alogliptin—Urticaria—Idarubicin—hematologic cancer	0.000603	0.00297	CcSEcCtD
Alogliptin—Anaphylactic shock—Imatinib—hematologic cancer	0.000598	0.00295	CcSEcCtD
Alogliptin—Hypersensitivity—Mercaptopurine—hematologic cancer	0.00059	0.00291	CcSEcCtD
Alogliptin—Urticaria—Teniposide—hematologic cancer	0.000586	0.00289	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Gemcitabine—hematologic cancer	0.000585	0.00288	CcSEcCtD
Alogliptin—Angioedema—Lenalidomide—hematologic cancer	0.000583	0.00288	CcSEcCtD
Alogliptin—Hypersensitivity—Daunorubicin—hematologic cancer	0.000582	0.00287	CcSEcCtD
Alogliptin—Hypersensitivity—Clofarabine—hematologic cancer	0.000582	0.00287	CcSEcCtD
Alogliptin—Hypersensitivity—Pentostatin—hematologic cancer	0.00058	0.00286	CcSEcCtD
Alogliptin—Erythema multiforme—Thalidomide—hematologic cancer	0.000575	0.00284	CcSEcCtD
Alogliptin—Hypersensitivity—Idarubicin—hematologic cancer	0.000559	0.00276	CcSEcCtD
Alogliptin—Erythema multiforme—Alitretinoin—hematologic cancer	0.000547	0.0027	CcSEcCtD
Alogliptin—Pancreatitis—Prednisolone—hematologic cancer	0.000546	0.00269	CcSEcCtD
Alogliptin—Hypersensitivity—Teniposide—hematologic cancer	0.000544	0.00268	CcSEcCtD
Alogliptin—Urticaria—Busulfan—hematologic cancer	0.000543	0.00268	CcSEcCtD
Alogliptin—Erythema multiforme—Ifosfamide—hematologic cancer	0.000541	0.00267	CcSEcCtD
Alogliptin—Diabetes mellitus—Prednisone—hematologic cancer	0.000538	0.00265	CcSEcCtD
Alogliptin—Angioedema—Bortezomib—hematologic cancer	0.000537	0.00265	CcSEcCtD
Alogliptin—Anaphylactic shock—Melphalan—hematologic cancer	0.000536	0.00264	CcSEcCtD
Alogliptin—Headache—Nelarabine—hematologic cancer	0.000529	0.00261	CcSEcCtD
Alogliptin—Urticaria—Procarbazine—hematologic cancer	0.000527	0.0026	CcSEcCtD
Alogliptin—Angioedema—Vinorelbine—hematologic cancer	0.000524	0.00258	CcSEcCtD
Alogliptin—Rash—Methoxsalen—hematologic cancer	0.00052	0.00256	CcSEcCtD
Alogliptin—Dermatitis—Methoxsalen—hematologic cancer	0.00052	0.00256	CcSEcCtD
Alogliptin—Headache—Methoxsalen—hematologic cancer	0.000517	0.00255	CcSEcCtD
Alogliptin—Urticaria—Dasatinib—hematologic cancer	0.000517	0.00255	CcSEcCtD
Alogliptin—Rash—Mercaptopurine—hematologic cancer	0.000505	0.00249	CcSEcCtD
Alogliptin—Dermatitis—Mercaptopurine—hematologic cancer	0.000505	0.00249	CcSEcCtD
Alogliptin—Hypersensitivity—Busulfan—hematologic cancer	0.000504	0.00249	CcSEcCtD
Alogliptin—Pancreatitis—Triamcinolone—hematologic cancer	0.000502	0.00248	CcSEcCtD
Alogliptin—Erythema multiforme—Gemcitabine—hematologic cancer	0.0005	0.00247	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Etoposide—hematologic cancer	0.000499	0.00246	CcSEcCtD
Alogliptin—Rash—Daunorubicin—hematologic cancer	0.000498	0.00246	CcSEcCtD
Alogliptin—Rash—Clofarabine—hematologic cancer	0.000498	0.00246	CcSEcCtD
Alogliptin—Dermatitis—Clofarabine—hematologic cancer	0.000498	0.00245	CcSEcCtD
Alogliptin—Dermatitis—Daunorubicin—hematologic cancer	0.000498	0.00245	CcSEcCtD
Alogliptin—Rash—Pentostatin—hematologic cancer	0.000496	0.00245	CcSEcCtD
Alogliptin—Rash—Anagrelide—hematologic cancer	0.000496	0.00245	CcSEcCtD
Alogliptin—Dermatitis—Pentostatin—hematologic cancer	0.000496	0.00244	CcSEcCtD
Alogliptin—Dermatitis—Anagrelide—hematologic cancer	0.000496	0.00244	CcSEcCtD
Alogliptin—Headache—Clofarabine—hematologic cancer	0.000495	0.00244	CcSEcCtD
Alogliptin—Headache—Daunorubicin—hematologic cancer	0.000495	0.00244	CcSEcCtD
Alogliptin—Headache—Anagrelide—hematologic cancer	0.000493	0.00243	CcSEcCtD
Alogliptin—Headache—Pentostatin—hematologic cancer	0.000493	0.00243	CcSEcCtD
Alogliptin—Hypersensitivity—Procarbazine—hematologic cancer	0.000489	0.00241	CcSEcCtD
Alogliptin—Urticaria—Chlorambucil—hematologic cancer	0.000488	0.00241	CcSEcCtD
Alogliptin—Angioedema—Thalidomide—hematologic cancer	0.000484	0.00239	CcSEcCtD
Alogliptin—Anaphylactic shock—Bortezomib—hematologic cancer	0.000479	0.00236	CcSEcCtD
Alogliptin—Hypersensitivity—Bexarotene—hematologic cancer	0.000479	0.00236	CcSEcCtD
Alogliptin—Hypersensitivity—Dasatinib—hematologic cancer	0.000479	0.00236	CcSEcCtD
Alogliptin—Rash—Idarubicin—hematologic cancer	0.000478	0.00236	CcSEcCtD
Alogliptin—Dermatitis—Idarubicin—hematologic cancer	0.000478	0.00236	CcSEcCtD
Alogliptin—Hypersensitivity—Fludarabine—hematologic cancer	0.000478	0.00236	CcSEcCtD
Alogliptin—Urticaria—Nilotinib—hematologic cancer	0.000478	0.00235	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Triamcinolone—hematologic cancer	0.000476	0.00235	CcSEcCtD
Alogliptin—Anaphylactic shock—Bleomycin—hematologic cancer	0.000476	0.00235	CcSEcCtD
Alogliptin—Headache—Idarubicin—hematologic cancer	0.000475	0.00234	CcSEcCtD
Alogliptin—Urticaria—Imatinib—hematologic cancer	0.000475	0.00234	CcSEcCtD
Alogliptin—Anaphylactic shock—Vinorelbine—hematologic cancer	0.000468	0.00231	CcSEcCtD
Alogliptin—Urticaria—Cladribine—hematologic cancer	0.000467	0.0023	CcSEcCtD
Alogliptin—Rash—Teniposide—hematologic cancer	0.000465	0.00229	CcSEcCtD
Alogliptin—Dermatitis—Teniposide—hematologic cancer	0.000465	0.00229	CcSEcCtD
Alogliptin—Headache—Teniposide—hematologic cancer	0.000462	0.00228	CcSEcCtD
Alogliptin—Angioedema—Ifosfamide—hematologic cancer	0.000455	0.00224	CcSEcCtD
Alogliptin—Hypersensitivity—Chlorambucil—hematologic cancer	0.000453	0.00223	CcSEcCtD
Alogliptin—Diabetes mellitus—Methotrexate—hematologic cancer	0.00045	0.00222	CcSEcCtD
Alogliptin—Hypersensitivity—Nilotinib—hematologic cancer	0.000443	0.00218	CcSEcCtD
Alogliptin—Hypersensitivity—Imatinib—hematologic cancer	0.00044	0.00217	CcSEcCtD
Alogliptin—DPP4—hematopoietic system—hematologic cancer	0.000434	0.197	CbGeAlD
Alogliptin—Hypersensitivity—Cladribine—hematologic cancer	0.000433	0.00213	CcSEcCtD
Alogliptin—Rash—Busulfan—hematologic cancer	0.000431	0.00213	CcSEcCtD
Alogliptin—Dermatitis—Busulfan—hematologic cancer	0.000431	0.00212	CcSEcCtD
Alogliptin—Headache—Busulfan—hematologic cancer	0.000429	0.00211	CcSEcCtD
Alogliptin—Erythema multiforme—Etoposide—hematologic cancer	0.000427	0.00211	CcSEcCtD
Alogliptin—Urticaria—Melphalan—hematologic cancer	0.000426	0.0021	CcSEcCtD
Alogliptin—Diabetes mellitus—Epirubicin—hematologic cancer	0.000421	0.00208	CcSEcCtD
Alogliptin—Rash—Procarbazine—hematologic cancer	0.000418	0.00206	CcSEcCtD
Alogliptin—Dermatitis—Procarbazine—hematologic cancer	0.000418	0.00206	CcSEcCtD
Alogliptin—Headache—Procarbazine—hematologic cancer	0.000416	0.00205	CcSEcCtD
Alogliptin—Hypersensitivity—Vinblastine—hematologic cancer	0.000415	0.00205	CcSEcCtD
Alogliptin—Urticaria—Lenalidomide—hematologic cancer	0.000414	0.00204	CcSEcCtD
Alogliptin—Anaphylactic shock—Alitretinoin—hematologic cancer	0.000411	0.00203	CcSEcCtD
Alogliptin—Rash—Bexarotene—hematologic cancer	0.00041	0.00202	CcSEcCtD
Alogliptin—Rash—Dasatinib—hematologic cancer	0.00041	0.00202	CcSEcCtD
Alogliptin—Dermatitis—Dasatinib—hematologic cancer	0.00041	0.00202	CcSEcCtD
Alogliptin—Dermatitis—Bexarotene—hematologic cancer	0.00041	0.00202	CcSEcCtD
Alogliptin—Rash—Fludarabine—hematologic cancer	0.000409	0.00202	CcSEcCtD
Alogliptin—Dermatitis—Fludarabine—hematologic cancer	0.000409	0.00202	CcSEcCtD
Alogliptin—Headache—Dasatinib—hematologic cancer	0.000408	0.00201	CcSEcCtD
Alogliptin—Headache—Bexarotene—hematologic cancer	0.000408	0.00201	CcSEcCtD
Alogliptin—Anaphylactic shock—Ifosfamide—hematologic cancer	0.000407	0.002	CcSEcCtD
Alogliptin—Headache—Fludarabine—hematologic cancer	0.000406	0.002	CcSEcCtD
Alogliptin—Pancreatitis—Prednisone—hematologic cancer	0.000397	0.00196	CcSEcCtD
Alogliptin—Anaphylactic shock—Vincristine—hematologic cancer	0.000396	0.00195	CcSEcCtD
Alogliptin—Hypersensitivity—Melphalan—hematologic cancer	0.000395	0.00195	CcSEcCtD
Alogliptin—Diabetes mellitus—Doxorubicin—hematologic cancer	0.00039	0.00192	CcSEcCtD
Alogliptin—Anaphylactic shock—Irinotecan—hematologic cancer	0.000386	0.0019	CcSEcCtD
Alogliptin—Anaphylactic shock—Mitoxantrone—hematologic cancer	0.000386	0.0019	CcSEcCtD
Alogliptin—Hypersensitivity—Lenalidomide—hematologic cancer	0.000384	0.00189	CcSEcCtD
Alogliptin—Urticaria—Bortezomib—hematologic cancer	0.000381	0.00188	CcSEcCtD
Alogliptin—Rash—Nilotinib—hematologic cancer	0.000379	0.00187	CcSEcCtD
Alogliptin—Dermatitis—Nilotinib—hematologic cancer	0.000379	0.00187	CcSEcCtD
Alogliptin—Hypersensitivity—Hydroxyurea—hematologic cancer	0.000378	0.00187	CcSEcCtD
Alogliptin—Urticaria—Bleomycin—hematologic cancer	0.000378	0.00186	CcSEcCtD
Alogliptin—Rash—Imatinib—hematologic cancer	0.000377	0.00186	CcSEcCtD
Alogliptin—Headache—Nilotinib—hematologic cancer	0.000377	0.00186	CcSEcCtD
Alogliptin—Dermatitis—Imatinib—hematologic cancer	0.000377	0.00186	CcSEcCtD
Alogliptin—Anaphylactic shock—Gemcitabine—hematologic cancer	0.000376	0.00185	CcSEcCtD
Alogliptin—Hypoglycaemia—Epirubicin—hematologic cancer	0.000375	0.00185	CcSEcCtD
Alogliptin—Headache—Imatinib—hematologic cancer	0.000374	0.00185	CcSEcCtD
Alogliptin—Urticaria—Vinorelbine—hematologic cancer	0.000372	0.00183	CcSEcCtD
Alogliptin—Rash—Cladribine—hematologic cancer	0.00037	0.00183	CcSEcCtD
Alogliptin—Dermatitis—Cladribine—hematologic cancer	0.00037	0.00182	CcSEcCtD
Alogliptin—Headache—Cladribine—hematologic cancer	0.000368	0.00181	CcSEcCtD
Alogliptin—Urticaria—Thiotepa—hematologic cancer	0.000355	0.00175	CcSEcCtD
Alogliptin—Angioedema—Prednisolone—hematologic cancer	0.000355	0.00175	CcSEcCtD
Alogliptin—Hypersensitivity—Bortezomib—hematologic cancer	0.000353	0.00174	CcSEcCtD
Alogliptin—Headache—Vinblastine—hematologic cancer	0.000353	0.00174	CcSEcCtD
Alogliptin—Anaphylactic shock—Cisplatin—hematologic cancer	0.00035	0.00173	CcSEcCtD
Alogliptin—Hypersensitivity—Bleomycin—hematologic cancer	0.00035	0.00173	CcSEcCtD
Alogliptin—Hypoglycaemia—Doxorubicin—hematologic cancer	0.000347	0.00171	CcSEcCtD
Alogliptin—Hypersensitivity—Vinorelbine—hematologic cancer	0.000345	0.0017	CcSEcCtD
Alogliptin—Urticaria—Thalidomide—hematologic cancer	0.000343	0.00169	CcSEcCtD
Alogliptin—Rash—Melphalan—hematologic cancer	0.000338	0.00167	CcSEcCtD
Alogliptin—Dermatitis—Melphalan—hematologic cancer	0.000337	0.00166	CcSEcCtD
Alogliptin—Pancreatitis—Methotrexate—hematologic cancer	0.000332	0.00163	CcSEcCtD
Alogliptin—Hypersensitivity—Thiotepa—hematologic cancer	0.000329	0.00162	CcSEcCtD
Alogliptin—Rash—Lenalidomide—hematologic cancer	0.000328	0.00162	CcSEcCtD
Alogliptin—Dermatitis—Lenalidomide—hematologic cancer	0.000328	0.00162	CcSEcCtD
Alogliptin—Nasopharyngitis—Epirubicin—hematologic cancer	0.000327	0.00161	CcSEcCtD
Alogliptin—Urticaria—Alitretinoin—hematologic cancer	0.000327	0.00161	CcSEcCtD
Alogliptin—Headache—Lenalidomide—hematologic cancer	0.000326	0.00161	CcSEcCtD
Alogliptin—Angioedema—Triamcinolone—hematologic cancer	0.000326	0.00161	CcSEcCtD
Alogliptin—Rash—Hydroxyurea—hematologic cancer	0.000324	0.0016	CcSEcCtD
Alogliptin—Dermatitis—Hydroxyurea—hematologic cancer	0.000324	0.0016	CcSEcCtD
Alogliptin—Urticaria—Ifosfamide—hematologic cancer	0.000323	0.00159	CcSEcCtD
Alogliptin—Headache—Hydroxyurea—hematologic cancer	0.000322	0.00159	CcSEcCtD
Alogliptin—Anaphylactic shock—Etoposide—hematologic cancer	0.000321	0.00158	CcSEcCtD
Alogliptin—Hypersensitivity—Thalidomide—hematologic cancer	0.000319	0.00157	CcSEcCtD
Alogliptin—Anaphylactic shock—Prednisolone—hematologic cancer	0.000317	0.00156	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Methotrexate—hematologic cancer	0.000314	0.00155	CcSEcCtD
Alogliptin—Pancreatitis—Epirubicin—hematologic cancer	0.00031	0.00153	CcSEcCtD
Alogliptin—Urticaria—Mitoxantrone—hematologic cancer	0.000307	0.00151	CcSEcCtD
Alogliptin—Hypersensitivity—Carmustine—hematologic cancer	0.000306	0.00151	CcSEcCtD
Alogliptin—Hypersensitivity—Alitretinoin—hematologic cancer	0.000303	0.00149	CcSEcCtD
Alogliptin—Nasopharyngitis—Doxorubicin—hematologic cancer	0.000303	0.00149	CcSEcCtD
Alogliptin—Rash—Bortezomib—hematologic cancer	0.000302	0.00149	CcSEcCtD
Alogliptin—Dermatitis—Bortezomib—hematologic cancer	0.000302	0.00149	CcSEcCtD
Alogliptin—Headache—Bortezomib—hematologic cancer	0.0003	0.00148	CcSEcCtD
Alogliptin—Rash—Bleomycin—hematologic cancer	0.0003	0.00148	CcSEcCtD
Alogliptin—Dermatitis—Bleomycin—hematologic cancer	0.0003	0.00148	CcSEcCtD
Alogliptin—Hypersensitivity—Ifosfamide—hematologic cancer	0.0003	0.00148	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Methotrexate—hematologic cancer	0.000299	0.00147	CcSEcCtD
Alogliptin—Angioedema—Dexamethasone—hematologic cancer	0.000296	0.00146	CcSEcCtD
Alogliptin—Angioedema—Betamethasone—hematologic cancer	0.000296	0.00146	CcSEcCtD
Alogliptin—Rash—Vinorelbine—hematologic cancer	0.000295	0.00146	CcSEcCtD
Alogliptin—Dermatitis—Vinorelbine—hematologic cancer	0.000295	0.00145	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Epirubicin—hematologic cancer	0.000294	0.00145	CcSEcCtD
Alogliptin—Headache—Vinorelbine—hematologic cancer	0.000293	0.00145	CcSEcCtD
Alogliptin—Hypersensitivity—Vincristine—hematologic cancer	0.000292	0.00144	CcSEcCtD
Alogliptin—Anaphylactic shock—Triamcinolone—hematologic cancer	0.000291	0.00144	CcSEcCtD
Alogliptin—DPP4—blood—hematologic cancer	0.000288	0.13	CbGeAlD
Alogliptin—Pancreatitis—Doxorubicin—hematologic cancer	0.000287	0.00142	CcSEcCtD
Alogliptin—Hypersensitivity—Irinotecan—hematologic cancer	0.000284	0.0014	CcSEcCtD
Alogliptin—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000284	0.0014	CcSEcCtD
Alogliptin—Rash—Thiotepa—hematologic cancer	0.000282	0.00139	CcSEcCtD
Alogliptin—Dermatitis—Thiotepa—hematologic cancer	0.000282	0.00139	CcSEcCtD
Alogliptin—Headache—Thiotepa—hematologic cancer	0.00028	0.00138	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Epirubicin—hematologic cancer	0.00028	0.00138	CcSEcCtD
Alogliptin—DPP4—bone marrow—hematologic cancer	0.000278	0.126	CbGeAlD
Alogliptin—Rash—Thalidomide—hematologic cancer	0.000273	0.00134	CcSEcCtD
Alogliptin—Dermatitis—Thalidomide—hematologic cancer	0.000272	0.00134	CcSEcCtD
Alogliptin—Upper respiratory tract infection—Doxorubicin—hematologic cancer	0.000272	0.00134	CcSEcCtD
Alogliptin—DPP4—Peptide hormone metabolism—ANPEP—hematologic cancer	0.000272	0.0683	CbGpPWpGaD
Alogliptin—DPP4—Peptide hormone metabolism—CTSZ—hematologic cancer	0.000272	0.0683	CbGpPWpGaD
Alogliptin—Headache—Thalidomide—hematologic cancer	0.000271	0.00134	CcSEcCtD
Alogliptin—Anaphylactic shock—Betamethasone—hematologic cancer	0.000264	0.0013	CcSEcCtD
Alogliptin—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000264	0.0013	CcSEcCtD
Alogliptin—Rash—Carmustine—hematologic cancer	0.000262	0.00129	CcSEcCtD
Alogliptin—Dermatitis—Carmustine—hematologic cancer	0.000262	0.00129	CcSEcCtD
Alogliptin—Headache—Carmustine—hematologic cancer	0.00026	0.00128	CcSEcCtD
Alogliptin—Rash—Alitretinoin—hematologic cancer	0.000259	0.00128	CcSEcCtD
Alogliptin—Dermatitis—Alitretinoin—hematologic cancer	0.000259	0.00128	CcSEcCtD
Alogliptin—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	0.000259	0.00128	CcSEcCtD
Alogliptin—Hypersensitivity—Cisplatin—hematologic cancer	0.000258	0.00127	CcSEcCtD
Alogliptin—Headache—Alitretinoin—hematologic cancer	0.000258	0.00127	CcSEcCtD
Alogliptin—Angioedema—Prednisone—hematologic cancer	0.000258	0.00127	CcSEcCtD
Alogliptin—Rash—Ifosfamide—hematologic cancer	0.000256	0.00126	CcSEcCtD
Alogliptin—Dermatitis—Ifosfamide—hematologic cancer	0.000256	0.00126	CcSEcCtD
Alogliptin—Erythema multiforme—Methotrexate—hematologic cancer	0.000256	0.00126	CcSEcCtD
Alogliptin—Urticaria—Etoposide—hematologic cancer	0.000255	0.00126	CcSEcCtD
Alogliptin—DPP4—lung—hematologic cancer	0.000252	0.114	CbGeAlD
Alogliptin—Urticaria—Prednisolone—hematologic cancer	0.000252	0.00124	CcSEcCtD
Alogliptin—Rash—Vincristine—hematologic cancer	0.00025	0.00123	CcSEcCtD
Alogliptin—Dermatitis—Vincristine—hematologic cancer	0.00025	0.00123	CcSEcCtD
Alogliptin—Headache—Vincristine—hematologic cancer	0.000248	0.00122	CcSEcCtD
Alogliptin—Rash—Mitoxantrone—hematologic cancer	0.000243	0.0012	CcSEcCtD
Alogliptin—Rash—Irinotecan—hematologic cancer	0.000243	0.0012	CcSEcCtD
Alogliptin—Dermatitis—Irinotecan—hematologic cancer	0.000243	0.0012	CcSEcCtD
Alogliptin—Dermatitis—Mitoxantrone—hematologic cancer	0.000243	0.0012	CcSEcCtD
Alogliptin—Headache—Irinotecan—hematologic cancer	0.000242	0.00119	CcSEcCtD
Alogliptin—Headache—Mitoxantrone—hematologic cancer	0.000242	0.00119	CcSEcCtD
Alogliptin—Erythema multiforme—Epirubicin—hematologic cancer	0.00024	0.00118	CcSEcCtD
Alogliptin—DPP4—testis—hematologic cancer	0.000238	0.108	CbGeAlD
Alogliptin—Rash—Gemcitabine—hematologic cancer	0.000237	0.00117	CcSEcCtD
Alogliptin—Dermatitis—Gemcitabine—hematologic cancer	0.000237	0.00117	CcSEcCtD
Alogliptin—Hypersensitivity—Etoposide—hematologic cancer	0.000237	0.00117	CcSEcCtD
Alogliptin—Headache—Gemcitabine—hematologic cancer	0.000236	0.00116	CcSEcCtD
Alogliptin—Hypersensitivity—Prednisolone—hematologic cancer	0.000233	0.00115	CcSEcCtD
Alogliptin—Urticaria—Triamcinolone—hematologic cancer	0.000231	0.00114	CcSEcCtD
Alogliptin—Anaphylactic shock—Prednisone—hematologic cancer	0.00023	0.00113	CcSEcCtD
Alogliptin—Erythema multiforme—Doxorubicin—hematologic cancer	0.000222	0.00109	CcSEcCtD
Alogliptin—Rash—Cisplatin—hematologic cancer	0.000221	0.00109	CcSEcCtD
Alogliptin—Dermatitis—Cisplatin—hematologic cancer	0.000221	0.00109	CcSEcCtD
Alogliptin—Hypersensitivity—Triamcinolone—hematologic cancer	0.000215	0.00106	CcSEcCtD
Alogliptin—Urticaria—Dexamethasone—hematologic cancer	0.00021	0.00104	CcSEcCtD
Alogliptin—Urticaria—Betamethasone—hematologic cancer	0.00021	0.00104	CcSEcCtD
Alogliptin—Rash—Etoposide—hematologic cancer	0.000202	0.000998	CcSEcCtD
Alogliptin—Dermatitis—Etoposide—hematologic cancer	0.000202	0.000997	CcSEcCtD
Alogliptin—Headache—Etoposide—hematologic cancer	0.000201	0.000992	CcSEcCtD
Alogliptin—Rash—Prednisolone—hematologic cancer	0.0002	0.000985	CcSEcCtD
Alogliptin—Dermatitis—Prednisolone—hematologic cancer	0.0002	0.000984	CcSEcCtD
Alogliptin—Headache—Prednisolone—hematologic cancer	0.000198	0.000978	CcSEcCtD
Alogliptin—Anaphylactic shock—Methotrexate—hematologic cancer	0.000192	0.000948	CcSEcCtD
Alogliptin—Rash—Triamcinolone—hematologic cancer	0.000184	0.000905	CcSEcCtD
Alogliptin—Dermatitis—Triamcinolone—hematologic cancer	0.000183	0.000905	CcSEcCtD
Alogliptin—Urticaria—Prednisone—hematologic cancer	0.000183	0.000901	CcSEcCtD
Alogliptin—Headache—Triamcinolone—hematologic cancer	0.000182	0.0009	CcSEcCtD
Alogliptin—Anaphylactic shock—Epirubicin—hematologic cancer	0.00018	0.000887	CcSEcCtD
Alogliptin—DPP4—lymph node—hematologic cancer	0.000172	0.0782	CbGeAlD
Alogliptin—Hypersensitivity—Prednisone—hematologic cancer	0.00017	0.000836	CcSEcCtD
Alogliptin—Rash—Dexamethasone—hematologic cancer	0.000167	0.000821	CcSEcCtD
Alogliptin—Rash—Betamethasone—hematologic cancer	0.000167	0.000821	CcSEcCtD
Alogliptin—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000167	0.000821	CcSEcCtD
Alogliptin—Dermatitis—Betamethasone—hematologic cancer	0.000166	0.000821	CcSEcCtD
Alogliptin—Dermatitis—Dexamethasone—hematologic cancer	0.000166	0.000821	CcSEcCtD
Alogliptin—Headache—Dexamethasone—hematologic cancer	0.000166	0.000816	CcSEcCtD
Alogliptin—Headache—Betamethasone—hematologic cancer	0.000166	0.000816	CcSEcCtD
Alogliptin—CYP3A4—Aflatoxin B1 metabolism—EPHX1—hematologic cancer	0.000156	0.0392	CbGpPWpGaD
Alogliptin—Urticaria—Methotrexate—hematologic cancer	0.000153	0.000753	CcSEcCtD
Alogliptin—Rash—Prednisone—hematologic cancer	0.000145	0.000715	CcSEcCtD
Alogliptin—Dermatitis—Prednisone—hematologic cancer	0.000145	0.000715	CcSEcCtD
Alogliptin—Headache—Prednisone—hematologic cancer	0.000144	0.000711	CcSEcCtD
Alogliptin—Urticaria—Epirubicin—hematologic cancer	0.000143	0.000705	CcSEcCtD
Alogliptin—Hypersensitivity—Methotrexate—hematologic cancer	0.000142	0.000699	CcSEcCtD
Alogliptin—CYP3A4—hematopoietic system—hematologic cancer	0.000142	0.0642	CbGeAlD
Alogliptin—CYP2D6—hematopoietic system—hematologic cancer	0.000139	0.0632	CbGeAlD
Alogliptin—CYP2D6—Codeine and Morphine Metabolism—ABCC3—hematologic cancer	0.000138	0.0347	CbGpPWpGaD
Alogliptin—DPP4—Peptide hormone metabolism—MME—hematologic cancer	0.000134	0.0338	CbGpPWpGaD
Alogliptin—DPP4—Peptide hormone metabolism—CMA1—hematologic cancer	0.000133	0.0334	CbGpPWpGaD
Alogliptin—Hypersensitivity—Epirubicin—hematologic cancer	0.000133	0.000654	CcSEcCtD
Alogliptin—Urticaria—Doxorubicin—hematologic cancer	0.000132	0.000652	CcSEcCtD
Alogliptin—CYP2D6—Codeine and Morphine Metabolism—UGT1A1—hematologic cancer	0.00013	0.0326	CbGpPWpGaD
Alogliptin—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—hematologic cancer	0.000127	0.032	CbGpPWpGaD
Alogliptin—Hypersensitivity—Doxorubicin—hematologic cancer	0.000123	0.000605	CcSEcCtD
Alogliptin—Rash—Methotrexate—hematologic cancer	0.000121	0.000598	CcSEcCtD
Alogliptin—Dermatitis—Methotrexate—hematologic cancer	0.000121	0.000597	CcSEcCtD
Alogliptin—Headache—Methotrexate—hematologic cancer	0.00012	0.000594	CcSEcCtD
Alogliptin—CYP2D6—Melatonin metabolism and effects—PER3—hematologic cancer	0.000119	0.0298	CbGpPWpGaD
Alogliptin—Rash—Epirubicin—hematologic cancer	0.000113	0.00056	CcSEcCtD
Alogliptin—Dermatitis—Epirubicin—hematologic cancer	0.000113	0.000559	CcSEcCtD
Alogliptin—Headache—Epirubicin—hematologic cancer	0.000113	0.000556	CcSEcCtD
Alogliptin—Rash—Doxorubicin—hematologic cancer	0.000105	0.000518	CcSEcCtD
Alogliptin—Dermatitis—Doxorubicin—hematologic cancer	0.000105	0.000517	CcSEcCtD
Alogliptin—Headache—Doxorubicin—hematologic cancer	0.000104	0.000514	CcSEcCtD
Alogliptin—CYP2D6—Melatonin metabolism and effects—PER2—hematologic cancer	0.000101	0.0253	CbGpPWpGaD
Alogliptin—CYP2D6—Melatonin metabolism and effects—CRY2—hematologic cancer	0.000101	0.0253	CbGpPWpGaD
Alogliptin—CYP2D6—Melatonin metabolism and effects—CRY1—hematologic cancer	0.000101	0.0253	CbGpPWpGaD
Alogliptin—CYP3A4—blood—hematologic cancer	9.38e-05	0.0425	CbGeAlD
Alogliptin—CYP2D6—blood—hematologic cancer	9.23e-05	0.0418	CbGeAlD
Alogliptin—CYP3A4—Codeine and Morphine Metabolism—ABCC3—hematologic cancer	9.02e-05	0.0227	CbGpPWpGaD
Alogliptin—CYP3A4—Codeine and Morphine Metabolism—UGT1A1—hematologic cancer	8.48e-05	0.0213	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—LDHD—hematologic cancer	7.96e-05	0.02	CbGpPWpGaD
Alogliptin—CYP2D6—Melatonin metabolism and effects—PER1—hematologic cancer	7.64e-05	0.0192	CbGpPWpGaD
Alogliptin—CYP2D6—testis—hematologic cancer	7.63e-05	0.0346	CbGeAlD
Alogliptin—CYP2D6—Codeine and Morphine Metabolism—ABCB1—hematologic cancer	7.02e-05	0.0176	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—GCNT4—hematologic cancer	6.03e-05	0.0152	CbGpPWpGaD
Alogliptin—CYP2D6—Melatonin metabolism and effects—ARNTL—hematologic cancer	5.44e-05	0.0137	CbGpPWpGaD
Alogliptin—CYP3A4—Irinotecan Pathway—UGT1A1—hematologic cancer	5.42e-05	0.0136	CbGpPWpGaD
Alogliptin—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hematologic cancer	5.31e-05	0.0133	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—CTSZ—hematologic cancer	5.13e-05	0.0129	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—ANPEP—hematologic cancer	5.13e-05	0.0129	CbGpPWpGaD
Alogliptin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—hematologic cancer	4.96e-05	0.0125	CbGpPWpGaD
Alogliptin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC3—hematologic cancer	4.93e-05	0.0124	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—ASNS—hematologic cancer	4.82e-05	0.0121	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—DPM1—hematologic cancer	4.82e-05	0.0121	CbGpPWpGaD
Alogliptin—CYP3A4—Irinotecan Pathway—ABCG2—hematologic cancer	4.7e-05	0.0118	CbGpPWpGaD
Alogliptin—CYP3A4—Codeine and Morphine Metabolism—ABCB1—hematologic cancer	4.59e-05	0.0115	CbGpPWpGaD
Alogliptin—CYP3A4—Estrogen metabolism—UGT1A1—hematologic cancer	4.43e-05	0.0111	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—PREB—hematologic cancer	4.36e-05	0.011	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—GCNT1—hematologic cancer	4.18e-05	0.0105	CbGpPWpGaD
Alogliptin—CYP3A4—Farnesoid X Receptor  Pathway—FGF19—hematologic cancer	3.99e-05	0.01	CbGpPWpGaD
Alogliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—hematologic cancer	3.59e-05	0.00901	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—MUC1—hematologic cancer	3.56e-05	0.00894	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—RPLP1—hematologic cancer	3.11e-05	0.00782	CbGpPWpGaD
Alogliptin—CYP3A4—Estrogen metabolism—NQO1—hematologic cancer	3.04e-05	0.00764	CbGpPWpGaD
Alogliptin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—hematologic cancer	2.97e-05	0.00748	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—TUBB2A—hematologic cancer	2.85e-05	0.00718	CbGpPWpGaD
Alogliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—hematologic cancer	2.83e-05	0.00713	CbGpPWpGaD
Alogliptin—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—hematologic cancer	2.8e-05	0.00703	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—MME—hematologic cancer	2.53e-05	0.00637	CbGpPWpGaD
Alogliptin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—hematologic cancer	2.51e-05	0.00631	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—CMA1—hematologic cancer	2.51e-05	0.0063	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—SUMO1—hematologic cancer	2.51e-05	0.0063	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—SPHK1—hematologic cancer	2.45e-05	0.00617	CbGpPWpGaD
Alogliptin—CYP2D6—Melatonin metabolism and effects—FOXO1—hematologic cancer	2.37e-05	0.00596	CbGpPWpGaD
Alogliptin—CYP3A4—Estrogen metabolism—GSTM1—hematologic cancer	2.33e-05	0.00585	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—RPS14—hematologic cancer	2.2e-05	0.00552	CbGpPWpGaD
Alogliptin—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—hematologic cancer	2.18e-05	0.00549	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—EIF4EBP1—hematologic cancer	1.92e-05	0.00483	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—SLC35B2—hematologic cancer	1.84e-05	0.00462	CbGpPWpGaD
Alogliptin—CYP2D6—Metapathway biotransformation—EPHX1—hematologic cancer	1.81e-05	0.00456	CbGpPWpGaD
Alogliptin—CYP3A4—Constitutive Androstane Receptor Pathway—HSP90AA1—hematologic cancer	1.8e-05	0.00453	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—HSPA5—hematologic cancer	1.78e-05	0.00447	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—CALR—hematologic cancer	1.72e-05	0.00433	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—FBXW7—hematologic cancer	1.67e-05	0.00419	CbGpPWpGaD
Alogliptin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—hematologic cancer	1.51e-05	0.00381	CbGpPWpGaD
Alogliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	1.44e-05	0.00363	CbGpPWpGaD
Alogliptin—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	1.43e-05	0.0036	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—SLC35B2—hematologic cancer	1.2e-05	0.00302	CbGpPWpGaD
Alogliptin—CYP3A4—Metapathway biotransformation—EPHX1—hematologic cancer	1.19e-05	0.00298	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—GSTO1—hematologic cancer	1.18e-05	0.00298	CbGpPWpGaD
Alogliptin—CYP2D6—Metapathway biotransformation—GSTO1—hematologic cancer	1.17e-05	0.00294	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—UGT1A1—hematologic cancer	1.11e-05	0.0028	CbGpPWpGaD
Alogliptin—CYP2D6—Metapathway biotransformation—UGT1A1—hematologic cancer	1.1e-05	0.00276	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—MTR—hematologic cancer	9.66e-06	0.00243	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—GSTT1—hematologic cancer	9.19e-06	0.00231	CbGpPWpGaD
Alogliptin—DPP4—Metabolism of proteins—CCL2—hematologic cancer	8.56e-06	0.00215	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	7.75e-06	0.00195	CbGpPWpGaD
Alogliptin—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	7.64e-06	0.00192	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	7.28e-06	0.00183	CbGpPWpGaD
Alogliptin—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	7.18e-06	0.00181	CbGpPWpGaD
Alogliptin—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	6.43e-06	0.00162	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—GSTP1—hematologic cancer	6.37e-06	0.0016	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—MTR—hematologic cancer	6.32e-06	0.00159	CbGpPWpGaD
Alogliptin—CYP2D6—Metapathway biotransformation—GSTP1—hematologic cancer	6.28e-06	0.00158	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	6.01e-06	0.00151	CbGpPWpGaD
Alogliptin—CYP2D6—Biological oxidations—GSTM1—hematologic cancer	5.85e-06	0.00147	CbGpPWpGaD
Alogliptin—CYP2D6—Metapathway biotransformation—GSTM1—hematologic cancer	5.77e-06	0.00145	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—FTCD—hematologic cancer	4.88e-06	0.00123	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—PHYH—hematologic cancer	4.88e-06	0.00123	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—GMPS—hematologic cancer	4.88e-06	0.00123	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—SMPD3—hematologic cancer	4.46e-06	0.00112	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	4.16e-06	0.00105	CbGpPWpGaD
Alogliptin—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	4.11e-06	0.00103	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ASNS—hematologic cancer	3.9e-06	0.000981	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—DCK—hematologic cancer	3.9e-06	0.000981	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—B3GAT1—hematologic cancer	3.9e-06	0.000981	CbGpPWpGaD
Alogliptin—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	3.83e-06	0.000962	CbGpPWpGaD
Alogliptin—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	3.77e-06	0.000949	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—HDC—hematologic cancer	3.7e-06	0.00093	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—CDA—hematologic cancer	3.38e-06	0.000851	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—PC—hematologic cancer	3.26e-06	0.000819	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—GMPS—hematologic cancer	3.19e-06	0.000802	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—PHYH—hematologic cancer	3.19e-06	0.000802	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—FTCD—hematologic cancer	3.19e-06	0.000802	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—SLC35B2—hematologic cancer	3.14e-06	0.000791	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—GBA—hematologic cancer	3.14e-06	0.000791	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—SMPD3—hematologic cancer	2.92e-06	0.000734	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—MTAP—hematologic cancer	2.88e-06	0.000723	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—FHL2—hematologic cancer	2.56e-06	0.000645	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—B3GAT1—hematologic cancer	2.55e-06	0.000641	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—DCK—hematologic cancer	2.55e-06	0.000641	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ASNS—hematologic cancer	2.55e-06	0.000641	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—AGRN—hematologic cancer	2.51e-06	0.000632	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—HDC—hematologic cancer	2.42e-06	0.000608	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—HMMR—hematologic cancer	2.38e-06	0.000599	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—IDH2—hematologic cancer	2.38e-06	0.000599	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ARNTL—hematologic cancer	2.24e-06	0.000563	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—CDA—hematologic cancer	2.21e-06	0.000556	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ACP5—hematologic cancer	2.18e-06	0.000548	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—CA9—hematologic cancer	2.18e-06	0.000548	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—NCOR2—hematologic cancer	2.15e-06	0.000541	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—PC—hematologic cancer	2.13e-06	0.000535	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—GBA—hematologic cancer	2.06e-06	0.000517	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—SLC35B2—hematologic cancer	2.06e-06	0.000517	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—IDH1—hematologic cancer	2.05e-06	0.000515	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—GSTO1—hematologic cancer	2.03e-06	0.00051	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ABCC3—hematologic cancer	2.03e-06	0.00051	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—TXN—hematologic cancer	2.03e-06	0.00051	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—SPHK1—hematologic cancer	1.98e-06	0.000499	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—UGT1A1—hematologic cancer	1.91e-06	0.000479	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—MTAP—hematologic cancer	1.88e-06	0.000473	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—SLC22A1—hematologic cancer	1.85e-06	0.000466	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—CRABP1—hematologic cancer	1.85e-06	0.000466	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ALOX5—hematologic cancer	1.81e-06	0.000454	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—NUP98—hematologic cancer	1.75e-06	0.00044	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ADCY7—hematologic cancer	1.7e-06	0.000427	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—NCOA3—hematologic cancer	1.7e-06	0.000427	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—NUP214—hematologic cancer	1.69e-06	0.000424	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—FHL2—hematologic cancer	1.68e-06	0.000421	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ABCG2—hematologic cancer	1.65e-06	0.000415	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—MTR—hematologic cancer	1.65e-06	0.000415	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—AGRN—hematologic cancer	1.64e-06	0.000413	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ENO2—hematologic cancer	1.62e-06	0.000407	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—GSTT1—hematologic cancer	1.57e-06	0.000395	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—IDH2—hematologic cancer	1.56e-06	0.000392	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—HMMR—hematologic cancer	1.56e-06	0.000392	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—SDC1—hematologic cancer	1.54e-06	0.000386	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ARNTL—hematologic cancer	1.46e-06	0.000368	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—CA9—hematologic cancer	1.43e-06	0.000358	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ACP5—hematologic cancer	1.43e-06	0.000358	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.41e-06	0.000354	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—IDH1—hematologic cancer	1.34e-06	0.000337	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—TXN—hematologic cancer	1.32e-06	0.000333	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.32e-06	0.000333	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.32e-06	0.000333	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—NQO1—hematologic cancer	1.31e-06	0.000328	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—CD44—hematologic cancer	1.31e-06	0.000328	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—SPHK1—hematologic cancer	1.3e-06	0.000326	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.25e-06	0.000313	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—CYCS—hematologic cancer	1.24e-06	0.000311	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	1.23e-06	0.000309	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.21e-06	0.000305	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.21e-06	0.000305	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.18e-06	0.000297	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—NUP98—hematologic cancer	1.14e-06	0.000288	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.11e-06	0.000279	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.11e-06	0.000279	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—NUP214—hematologic cancer	1.1e-06	0.000277	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—GSTP1—hematologic cancer	1.09e-06	0.000274	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—MTR—hematologic cancer	1.08e-06	0.000272	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.08e-06	0.000272	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ENO2—hematologic cancer	1.06e-06	0.000266	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ABCB1—hematologic cancer	1.03e-06	0.000259	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.03e-06	0.000258	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—SDC1—hematologic cancer	1e-06	0.000252	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—NCOR1—hematologic cancer	1e-06	0.000252	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—GSTM1—hematologic cancer	1e-06	0.000252	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—MTHFR—hematologic cancer	8.85e-07	0.000222	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—NQO1—hematologic cancer	8.54e-07	0.000215	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—CD44—hematologic cancer	8.54e-07	0.000215	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—CYCS—hematologic cancer	8.08e-07	0.000203	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	8.03e-07	0.000202	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—PIK3CG—hematologic cancer	7.43e-07	0.000187	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—GSTP1—hematologic cancer	7.12e-07	0.000179	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—CREBBP—hematologic cancer	6.89e-07	0.000173	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ABCB1—hematologic cancer	6.74e-07	0.000169	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—NCOR1—hematologic cancer	6.54e-07	0.000165	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—GSTM1—hematologic cancer	6.54e-07	0.000165	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—PIK3CD—hematologic cancer	6.53e-07	0.000164	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—ALB—hematologic cancer	6.45e-07	0.000162	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—PIK3R1—hematologic cancer	6.17e-07	0.000155	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—MTHFR—hematologic cancer	5.78e-07	0.000145	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—PIK3CB—hematologic cancer	5.69e-07	0.000143	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—PTEN—hematologic cancer	4.92e-07	0.000124	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—PIK3CG—hematologic cancer	4.86e-07	0.000122	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—EP300—hematologic cancer	4.69e-07	0.000118	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—CREBBP—hematologic cancer	4.5e-07	0.000113	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—PIK3CD—hematologic cancer	4.27e-07	0.000107	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—ALB—hematologic cancer	4.22e-07	0.000106	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—PIK3R1—hematologic cancer	4.03e-07	0.000101	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—PIK3CB—hematologic cancer	3.72e-07	9.36e-05	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—PIK3CA—hematologic cancer	3.47e-07	8.73e-05	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—PTEN—hematologic cancer	3.22e-07	8.09e-05	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—EP300—hematologic cancer	3.07e-07	7.71e-05	CbGpPWpGaD
Alogliptin—CYP2D6—Metabolism—AKT1—hematologic cancer	2.84e-07	7.13e-05	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—PIK3CA—hematologic cancer	2.27e-07	5.71e-05	CbGpPWpGaD
Alogliptin—CYP3A4—Metabolism—AKT1—hematologic cancer	1.85e-07	4.66e-05	CbGpPWpGaD
